Tender detail

New active substances for itemised reimbursement

Summary

Hungary’s National Health Insurance Fund Management procures medicines containing 11 active substances for healthcare institutions under framework agreements. The lots cover trastuzumab emtansine, pertuzumab, trastuzumab deruxtecan, anifrolumab, nivolumab with relatlimab, deucravacitinib, tucatinib, zanubrutinib, encorafenib, binimetinib and filgotinib. Each lot has a stated base quantity and an optional additional quantity, with supplies intended for the treatment of patients in the relevant therapeutic areas.

Reference number
801677-2026
Buyer
Nemzeti Egészségbiztosítási Alapkezelő
Country
Hungary (HUN)
Procedure
Open procedure
CPV
33690000 Various medicinal products
Deadline
2026-12-02
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.